Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1/2 1

Status

Completed 11Recruiting 3Terminated 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 98Lymphoid 48Other hematologic neoplasm 37Thoracic 7Genitourinary 6Gastrointestinal 5CNS 4Breast 4Tumor-Agnostic 3Myeloid 3Gynecologic 2Other solid neoplasm 1Head & Neck 1Endocrine 1Classical hematology 1

Conditions

Neoplasms 2Carcinoma 1

Interventions

pembrolizumab 25Specimen Handling 17Blood Specimen Collection 17Biopsy 16Magnetic Resonance Spectroscopy 15atezolizumab 11Surveys and Questionnaires 11Radiosurgery 9Bevacizumab 9Paclitaxel 8Fluorouracil 8Standard of Care 7Radiotherapy 7Nivolumab 7Irinotecan 7Gemcitabine 7Cisplatin 7Carboplatin 7olaparib 6durvalumab 6Palliative Care 6Oxaliplatin 6Leucovorin 6Cyclophosphamide 6Capecitabine 6alectinib 5abemaciclib 5Trastuzumab 5Interviews as Topic 5Exercise 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Dexamethasone × Tumor-Agnostic × Clear all
NCT05977998 2026-05-22

A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled
Tumor-Agnostic

Carcinoma

NCT02813135 2026-01-16

ESMART

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting
472 enrolled
Tumor-Agnostic

Neoplasms

NCT06118710 2024-09-25

DEXASTOP

Erasmus Medical Center

Phase 4 Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡